Wickremaratchi MM, Ben-Shlomo Y, Morris HR (2009) The effect of onset age on the clinical features of Parkinson’s disease. Eur J Neurol 16(4):450–456
CAS
PubMed
Article
Google Scholar
Antonini A, Barone P, Marconi R, Morgante L, Zappulla S, Pontieri FE, Ramat S, Ceravolo MG, Meco G, Cicarelli G, Pederzoli M, Manfredi M, Ceravolo R, Mucchiut M, Volpe G, Abbruzzese G, Bottacchi E, Bartolomei L, Ciacci G, Cannas A, Randisi MG, Petrone A, Baratti M, Toni V, Cossu G, Del Dotto P, Bentivoglio AR, Abrignani M, Scala R, Pennisi F, Quatrale R, Gaglio RM, Nicoletti A, Perini M, Avarello T, Pisani A, Scaglioni A, Martinelli PE, Iemolo F, Ferigo L, Simone P, Soliveri P, Troianiello B, Consoli D, Mauro A, Lopiano L, Nastasi G, Colosimo C (2012) The progression of non-motor symptoms in Parkinson’s disease and their contribution to motor disability and quality of life. J Neurol 259(12):2621–2631
PubMed
Article
Google Scholar
Valente EM, Arena G, Torosantuccia L, Gelmetti V (2012) Molecular pathways in sporadic PD. Parkinsonism and Relat Disord 18:S71–S73
Article
Google Scholar
Sachdev PS (2005) Homocysteine and brain atrophy. Prog Neuropsychopharmacol Biol Psychiatry 29(7):1152–1161
CAS
PubMed
Article
Google Scholar
Duan W, Ladenheim B, Cutler RG, Kruman II, Cadet JL, Mattson MP (2002) Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson’s disease. J Neurochem 80:101–110
CAS
PubMed
Article
Google Scholar
Doshi SN, Goodfellow J, Lewis MJ, McDowell IF (1999) Homocysteine and endothelial function. Cardiovasc Res 42(3):578–582
CAS
PubMed
Article
Google Scholar
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP (2012) The relationship between cerebral vascular disease and parkinsonism: the VADO study. Parkinsonism Relat Disord 18(6):775–780
CAS
PubMed
Article
Google Scholar
de Lau LM, Koudstaal PJ, van Meurs JB, Uitterlinden AG, Hofman A, Breteler MM (2005) Methylenetetrahydrofolate reductase C677T genotype and PD. Ann Neurol 57(6):927–930
PubMed
Article
Google Scholar
Wüllner U, Kölsch H, Linnebank M (2005) Methylenetetrahydrofolate reductase in Parkinson’s disease. Ann Neurol 58(6):972–973
PubMed
Article
Google Scholar
Yasui K, Kowa H, Nakaso K, Takeshima T, Nakashima K (2000) Plasma homocysteine and MTHFR C677T genotype in levodopa patients with PD. Neurology 55(3):437–440
CAS
PubMed
Article
Google Scholar
Lin JJ, Yueh KC, Liu CS, Liu JT, Lin SZ (2007) 5,10-Methylenetetrahydrofolate reductase C677T polymorphism can influence age at onset of Parkinson’s disease. Acta Neurol Taiwan 16(3):150–157
PubMed
Google Scholar
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. McHugh PR. J Psychiatry Res 12(3):189–198
CAS
Article
Google Scholar
Scheltens P, Barkhof F, Leys D, Pruvo JP, Nauta JJ, Vermersch P, Steinling M, Valk J (1993) A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 114(1):7–12
CAS
PubMed
Article
Google Scholar
Butler Rob, Morris Andrew D, Struthers Allan D (2002) Polymorphism may protect endothelial function in young, normal subjects the T Allele of the C677T 5,10-Methylenetetrahydrofolate reductase (MTHFR) gene. Arterioscler Thromb Vasc Biol 22:193–194
CAS
PubMed
Google Scholar
Spence MS, McGlinchey PG, Patterson CC, Belton C, Murphy G, McMaster D, Fogarty DG, Evans AE, McKeown PP (2002) Family-based investigation of the C677T polymorphism of the methylenetetrahydrofolate reductase gene in ischaemic heart disease. Atherosclerosis 165(2):293–299
CAS
PubMed
Article
Google Scholar
Jacques PF, Bostom AG, Williams RR, Curtis Ellison R, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93:7–9
CAS
PubMed
Article
Google Scholar
Kilarski LL, Pearson JP, Newsway V, Majounie E, Knipe MD, Misbahuddin A, Chinnery PF, Brucia DJ, Clarke CE, Marion MH, Lewthwaite AJ, Nicholl DJ, Legno NW, Morrison KE, Williams-Gray CH, Evans JR, Sawcer SJ, Barker RA, Wickremaratchi MM, Ben-Shlomo Y, Williams NM, Morris HR (2012) Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson’s disease. Mov Disord 12:1522–1529
Article
Google Scholar